With 1.03 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.05 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $39.68 whereas the lowest price it dropped to was $38.73. The 52-week range on WAY shows that it touched its highest point at $48.11 and its lowest point at $20.26 during that stretch. It currently has a 1-year price target of $49.64.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of WAY was up-trending over the past week, with a rise of 5.39%, but this was down by -7.51% over a month. Three-month performance surged to 9.64% while six-month performance rose 42.37%. A look at the trailing 12-month EPS for WAY yields -0.12 with Next year EPS estimates of 1.48. For the next quarter, that number is 0.32. This implies an EPS growth rate of 20.63% for this year and 12.42% for next year.
Float and Shares Shorts:
At present, 172.11 million WAY shares are outstanding with a float of 97.44 million shares on hand for trading. On 2025-03-14, short shares totaled 4.43 million, which was 257.99999 higher than short shares on 1739491200. In addition to Mr. Matthew J. Hawkins as the firm’s CEO & Director, Mr. Christopher L. Schremser serves as its Chief Technology Officer.
Institutional Ownership:
Through their ownership of 0.91931 of WAY’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-12-31, WAY reported revenue of $244102000.0 and operating income of $53143000.0. The EBITDA in the recently reported quarter was $91174000.0 and diluted EPS was $0.11.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for WAY since 8 analysts follow the stock currently. There are 8 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With WAY analysts setting a high price target of 55.0 and a low target of 45.0, the average target price over the next 12 months is 49.63636. Based on these targets, WAY could surge 41.35% to reach the target high and rise by 15.65% to reach the target low. Reaching the average price target will result in a growth of 27.57% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.32664 being high and $0.31293 being low. For WAY, this leads to a yearly average estimate of $0.31643. Based on analyst estimates, the high estimate for the next quarter is $0.33 and the low estimate is $0.32. The average estimate for the next quarter is thus $0.32.
